Welcome to our dedicated page for Colgate Palmolive Co news (Ticker: CL), a resource for investors and traders seeking the latest updates and insights on Colgate Palmolive Co stock.
News about Colgate-Palmolive Company (NYSE: CL) covers a wide range of topics, from quarterly earnings and financial guidance to dividends, share repurchase programs and product announcements. The company regularly issues press releases and hosts webcasts to discuss its performance in Oral Care, Personal Care, Home Care and Pet Nutrition, as well as its broader corporate strategy.
Investors following CL news will see detailed earnings updates, including net sales trends, organic sales growth, gross profit margin and non-GAAP Base Business results. Colgate-Palmolive’s releases also discuss divisional performance across North America, Latin America, Europe, Asia Pacific, Africa/Eurasia and the Hill’s pet nutrition division, along with commentary from senior management on category growth, advertising investment and long-term targets.
Corporate actions are another recurring theme in Colgate-Palmolive news. The Board of Directors frequently announces quarterly cash dividends and has highlighted that the company has paid uninterrupted dividends on its common stock since 1895. News items also include information on dividend increases and share repurchase authorizations, such as the $5 billion share repurchase program announced in March 2025.
Product and brand developments appear in the news flow as well. For example, Tom’s of Maine, a Colgate-Palmolive company, has issued releases about new oral care products under its natural personal care positioning. Colgate-Palmolive’s own communications also emphasize its sustainability initiatives and community programs, including the Colgate Bright Smiles, Bright Futures oral health education program. Together, these updates provide context on how the company manages its global portfolio of brands, finances and long-term priorities.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) has opened its tenth dispensary in Illinois, located in Naperville, a key retail area near major stores like Costco and Whole Foods. This marks a significant milestone as Cresco becomes the first cannabis operator to reach ten dispensaries in the state. The Sunnyside Naperville dispensary spans nearly 8,400 square feet and will employ approximately 40 staff, featuring 12 points of sale. Illinois cannabis retail sales are projected at over $1 billion annually, with Cresco's stores capturing a substantial market share.
Summary not available.
Cresco Labs (CSE:CL) (OTCQX:CRLBF), a major cannabis operator in the U.S., has extended its distribution agreement with Kings Garden Inc., a leading California cannabis brand. This agreement allows Cresco's subsidiary, Continuum, to continue as the exclusive distributor of Kings Garden products, enhancing their market presence. Kings Garden is recognized for its premium cannabis products and strong sales performance. The partnership is expected to boost growth and market share for both companies in California, one of Cresco's key markets.
Cresco Labs (CSE:CL, OTCQX:CRLBF) expands its Good News brand to Michigan, tapping into a rapidly growing cannabis market worth nearly $600 million. The launch features gummy edibles crafted for different moods — Me Time (Indica), Brunch (Hybrid), Friyay (Sativa), and Vegas (Sativa). Michigan, now the tenth state to legalize adult-use cannabis, generated over $104 million in sales in October alone. This expansion adds to Cresco’s portfolio, which includes brands like Mindy’s and High Supply, enhancing product variety for both medical and recreational consumers.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) has finalized an agreement with lenders to extend the maturity of its senior secured term loan to January 23, 2023, with a reduced interest rate of 12% annually. The loan size will increase to $200 million, with $85 million from existing and new institutional lenders. This funding aims to support Cresco's expansions across nine states and other growth initiatives. CEO Charlie Bachtell emphasized the positive implications of this financing in enhancing the company’s operational flexibility and capital efficiency.
Colgate's recent research indicates that its toothpastes containing zinc and stannous, along with mouthwashes with cetylpyridinium chloride, can neutralize COVID-19 by 99.9%. Laboratory studies showed Colgate Total and Meridol toothpastes had this effect after two minutes, while Colgate mouthwashes were effective after just 30 seconds. A clinical study involving 50 hospitalized COVID-19 patients is underway, revealing these products can temporarily reduce viral load in the mouth. Colgate is collaborating on further research to explore potential roles of oral care in reducing COVID-19 transmission.
Colgate-Palmolive (NYSE:CL) Group President Panagiotis Tsourapas will engage in a virtual fireside chat at the Morgan Stanley Global Consumer & Retail Conference on December 2, 2020, at 11:00 a.m. ET. Investors can access the live webcast on Colgate's website, and a recorded version will be available later. Colgate-Palmolive focuses on health-related products across various sectors, aiming for sustainable growth and superior shareholder returns. For further details about their initiatives, visit www.colgatepalmolive.com.
Summary not available.
Colgate-Palmolive Company (NYSE:CL) announced the appointment of Stanley J. Sutula as the new Chief Financial Officer, effective November 9, 2020. Sutula, currently serving as CFO at Pitney Bowes, brings extensive experience from his previous 28 years at IBM. He is recognized for leveraging technology and data analytics to drive revenue growth. Henning Jakobsen, the outgoing CFO, will transition to a Senior Vice President role until his retirement at the end of 2020. The leadership change aims to strengthen Colgate's financial strategies and performance.
Colgate-Palmolive Company (NYSE:CL) reported robust third quarter results for 2020, with net sales rising by 5.5% to $4,153 million and organic sales up 7.5%. GAAP EPS increased 21% to $0.81, while Base Business EPS rose 11% to $0.79. Gross profit margin improved by 220 basis points to 61.2%. Market leadership was maintained in toothpaste (39.9% share) and manual toothbrushes (31.1% share). The company expects full-year sales to rise by mid-single digits, alongside earnings growth. Enhanced advertising investments and premium innovations are driving the positive momentum.